Vision & Mission

REM is specifically focused on endogenous repair or how the body can harness its own potential to heal or regenerate. Bone, muscle, nerves, heart, blood vessels, and other tissues each have a baseline ability to regenerate. REM investigators ask what can be done when trauma or disease in humans overwhelms the ability of tissues or organs to regenerate on their own.


The integration of engineering technologies, biological discoveries, and clinical expertise and infrastructure will establish Georgia as a national leader in regenerative clinical therapies.


To fundamentally transform treatment outcomes for human diseases and injuries through the development and translation of new technologies that enhance the body's ability to heal itself. Targeted unmet clinical needs include musculoskeletal degeneration and injuries, cardiovascular disease, inflammatory and immune disorders, pediatric disorders, metabolic organ failure, neurological diseases, and soft tissue and bone injuries.

Companies that REM Has Helped Develop:

  • AlphaStem
  • ArunA Biomedical
  • BioSequent
  • Cambium Medical Technologies
  • Carticept Medical
  • CellCellect
  • Clearside Biomedical
  • Graft Solutions
  • Ketal Biomedical
  • MiMedx
  • Orthonics
  • Regeneration Matrix
  • Revitus
  • SaluMedica
  • Spheringenics
  • Vertera Spine
  • Zenda Technologies